[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358881-105":59,"doc-detail-358881-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","highly-sensitive-profiling-somatic-mutations-of-thyroid-cancer-by-nucleotide-enrichment-based-maldi-tof-ms-assay-research-paper","Highly sensitive profiling somatic mutations of thyroid cancer by nucleotide-enrichment-based MALDI-TOF MS assay - Research paper","","Multiple mutation detection is increasingly necessary for thyroid cancer diagnosis, therapy selection, and prognosis evaluation, especially when only limited fine-needle aspiration (FNA) material is available. However, cost-effective methods that simultaneously deliver high sensitivity and high throughput are lacking. This study introduces NE-MS, a multiplex approach combining nucleotide enrichment with MALDI-TOF MS to identify 26 somatic hotspot mutations. NE-MS achieves an 8-fold lower LOD than regular MS and supports diagnostic and prognostic assessment.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/highly-sensitive-profiling-somatic-mutations-of-thyroid-cancer-by-nucleotide-enrichment-based-maldi-tof-ms-assay-research-paper/358881/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/highly-sensitive-profiling-somatic-mutations-of-thyroid-cancer-by-nucleotide-enrichment-based-maldi-tof-ms-assay-research-paper/358881.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is multiplex somatic mutation detection important in thyroid cancer?","Question",{"text":113,"@type":114},"It supports diagnosis, treatment decision-making, and prognosis assessment, particularly when FNA samples are limited and tumors may carry multiple relevant mutations.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is NE-MS and what does it enable?",{"text":118,"@type":114},"NE-MS integrates nucleotide enrichment-assisted identification of variant alleles with MALDI-TOF MS, enabling simultaneous detection of 26 thyroid cancer somatic hotspot mutations.",{"name":120,"@type":111,"acceptedAnswer":121},"How does NE-MS improve sensitivity compared with regular MS?",{"text":122,"@type":114},"It improves sensitivity by producing an 8-fold lower limit of detection (LOD) than the regular MS method through removal of wild-type mass-modified ddNTP matching during single-base extension.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},358881,1790472757,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nHighly sensitive profiling somatic mutations of thyroid cancer by nucleotide-enrichment-based MALDI-TOF MS assay  \nHuili Bai1, Ying Li1, Jia Li1, Ting Liu2,3, Jun Xiao1, Lihui Xia1, Xueqin Sun1 & Wei Cheng1􀀍  \nMultiple mutation detection is increasingly essential for clinical applications targeting the diagnosis, treatment decision-making, and prognosis assessment of thyroid cancer, especially for the limited amount of thyroid fine-needle aspiration (FNA) samples. However, there is a lack of cost-effective methods that can simultaneously achieve high sensitivity and high throughput for thyroid cancer. Herein, we present a novel multiplex mutation detection technology that integrates nucleotide enrichment (NE)-assisted specific identification of variant alleles with matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF MS), termed NE-MS, enabling the simultaneous identification of 26 somatic hotspot mutations in thyroid cancer. This method enhances sensitivity by removing the mass-modified dideoxynucleotide (ddNTP) matching the wild-type from the nucleotide mixture during the single-base extension reaction, leaving the mutant alleles available for analysis. NE-MS exhibits an 8-fold lower LOD compared to the regular MS method. This strategy provided an excellent diagnostic performance for thyroid cancer, revealing that multiple mutations are associated with poor prognosis in thyroid cancer patients. Accordingly, this study demonstrated that the NE-MS assay is a highly sensitive and reliable initial screening method for somatic mutation detection, as well as a diagnostic and prognostic tool for thyroid nodules.  \nKeywords Dideoxynucleotide (ddNTP), NE-MS, Z-score, Somatic mutations, Diagnostic and prognostic  \nThyroid cancer is the most common endocrine tumor, with the ninth-highest cancer incidence worldwide and the third-most common cancer in women in China1,2. Thyroid fine needle aspiration (FNA) biopsy is the primary method to evaluate the malignancy of thyroid nodules, but approximately one-third of indeterminate thyroid nodules still undergo molecular testing for diagnosis3. Although the prognosis of papillary thyroid cancer (PTC) is generally favorable, up to 20% of patients may have a recurrence risk4,5. Recent data suggest that specific molecular profiles, such as the co-existence of BRAF with other oncogenic mutations (such as TERT and PIK3CA), may serve as less favorable outcomes of thyroid cancer6,7. The American Thyroid Association (ATA) risk stratification system categorizes the co-existence of BRAF with TERT mutations into high levels8. Therefore, the clinical precision management of thyroid cancer requires comprehensive analyses utilizing multiple mutation profiling.  \nCurrent clinical approaches for detecting molecular profiles primarily include real-time quantitative polymerase chain reaction (qRT-PCR), droplet digital PCR (ddPCR), Sanger sequencing, and next-generation sequencing (NGS)9–11. These technologies are widely used in clinical practice but have shortcomings. For instance, qRT-PCR and ddPCR methods are rapid and cost-effective tools that struggle to detect multiple mutations effectively. In addition, Sanger sequencing has an LOD of 10%, rendering it inadequate for identifying low-abundance mutations12. NGS often provides broad coverage of genes or hotspot of up to several hundred genes with improved sensitivity, but limitations include the high cost and long turnaround time of approximately ten days, which may be incompatible with the demands of timely clinical decision-making13. Therefore, an adaptable, rapid, and multiplex detection method is highly demanded for screening somatic variants for thyroid cancer.  \n1The Center for Clinical Molecular Medical Detection, Innovative and Translational Laboratory of Molecular Diagnostics, Laboratory Medicine Center, The First Affiliated Hospital of","cbCair8hccqeNX4k","https://ap.wps.com/l/cbCair8hccqeNX4k","pdf",2592763,11,"English","# Introduction\n## Clinical need for multiplex mutation profiling\n## Limitations of existing mutation-detection technologies\n# NE-MS assay concept\n## MassARRAY and single-base extension principles\n## Challenges of SBE-MALDI-TOF for low abundance mutations\n## Approaches to improve sensitivity and assay fidelity","[{\"question\":\"Why is multiplex somatic mutation detection important in thyroid cancer?\",\"answer\":\"It supports diagnosis, treatment decision-making, and prognosis assessment, particularly when FNA samples are limited and tumors may carry multiple relevant mutations.\"},{\"question\":\"What is NE-MS and what does it enable?\",\"answer\":\"NE-MS integrates nucleotide enrichment-assisted identification of variant alleles with MALDI-TOF MS, enabling simultaneous detection of 26 thyroid cancer somatic hotspot mutations.\"},{\"question\":\"How does NE-MS improve sensitivity compared with regular MS?\",\"answer\":\"It improves sensitivity by producing an 8-fold lower limit of detection (LOD) than the regular MS method through removal of wild-type mass-modified ddNTP matching during single-base extension.\"}]","Highly sensitive profiling somatic mutations of thyroid cancer by nucleotide-enrichment-based MALDI-TOF MS assay - Research paper | PDF",1790135538,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd5dd77d37fa412400306c733fb5ad39.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c249c2bdf8ec2410d9c69ffd514f9903.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0fc6af83ca5a1b63fbbef9db1aa025f.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/608b2d463e34d828db0df45fc7085ec6.webp",980,1287]